SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.1 (50 microgrammes/50 microgrammes)/ml, dispersion injectable, Vaccin à ARNm contre la COVID-19 — 10 flacon(s) multidose(s) en verre de 5 dose(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930259528
  • CIP7 3025952
  • CIS 62609613
  • Registration number EU/1/20/1507

What the source publishes

Holder
MODERNA BIOTECH SPAIN SL (ESPAGNE)
Active ingredients
IMÉLASOMÉRAN, ÉLASOMÉRAN
Form
dispersion injectable
Package
10 flacon(s) multidose(s) en verre de 5 dose(s)
Routes
intramusculaire
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2022-09-01
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930259528
{
  "cis": "62609613",
  "cip7": "3025952",
  "form": "dispersion injectable",
  "name": "SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.1 (50 microgrammes/50 microgrammes)/ml, dispersion injectable, Vaccin à ARNm contre la COVID-19 — 10 flacon(s) multidose(s) en verre de 5 dose(s)",
  "cip13": "3400930259528",
  "holder": "MODERNA BIOTECH SPAIN SL (ESPAGNE)",
  "routes": [
    "intramusculaire"
  ],
  "holders": [
    "MODERNA BIOTECH SPAIN SL (ESPAGNE)"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2022-09-01",
  "compositions": [
    {
      "name": "IMÉLASOMÉRAN",
      "nature": "SA",
      "strength": "25 microgrammes",
      "linkageNumber": "2",
      "substanceCode": "35463",
      "dosageReference": "une dose de 0,5 mL ou 12,5 microgrammes pour une dose de 0,25 mL",
      "pharmaceuticalElement": "dispersion"
    },
    {
      "name": "ÉLASOMÉRAN",
      "nature": "SA",
      "strength": "25 microgrammes",
      "linkageNumber": "1",
      "substanceCode": "43288",
      "dosageReference": "une dose de 0,5 mL ou 12,5 microgrammes pour une dose de 0,25 mL",
      "pharmaceuticalElement": "dispersion"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.1 (50 microgrammes/50 microgrammes)/ml, dispersion injectable, Vaccin à ARNm contre la COVID-19",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "10 flacon(s) multidose(s) en verre de 5 dose(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2023-01-30",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": true,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "IMÉLASOMÉRAN",
    "ÉLASOMÉRAN"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/20/1507",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930259528"